Canada · Delayed Price · Currency is CAD Planet 13 Holdings Earnings Call Transcripts
Fiscal Year 2026
-
The meeting confirmed quorum, elected seven directors, approved an equity plan amendment, and ratified the auditor. All proposals passed by majority vote, and no questions were submitted during the Q&A session.
-
Q1 2026 results reflected transition costs from strategic repositioning, with revenue at $21.1 million and improved gross margin. Regulatory changes, including federal rescheduling and stricter hemp rules, are expected to benefit operations and margins in the second half of 2026.
Fiscal Year 2025
-
Q4 saw sequential revenue and margin improvement, driven by operational stabilization, the California exit, and strong Florida growth. Regulatory changes in Nevada and federal momentum for cannabis rescheduling are expected to provide significant tailwinds in 2026.
-
Q3 revenue declined due to Nevada tourism drop and Florida operational issues, but October showed sequential improvement. Strategic exit from California and cost controls are expected to boost margins, with Florida and Illinois showing positive momentum.
-
Q2 2025 revenue declined to $26.9M amid challenging Nevada and Florida markets, but gross margin improved to 43.4% and cost reduction efforts began to yield results. The company is focused on operational discipline, expanding product offerings, and capital efficiency.
-
Q1 2025 revenue rose year-over-year to $28M, driven by the VidaCann acquisition, but sequentially declined due to seasonality and market headwinds. Cost-saving initiatives and operational realignment are underway, with a focus on Florida and Nevada to restore profitability and cash flow.
Fiscal Year 2024
-
Q4 revenue rose year-over-year but declined sequentially due to seasonal and pricing pressures, especially in Florida. Gross margin fell to 43.2%, but margin recovery is expected as upgraded greenhouses improve product quality. Balance sheet remains strong with minimal debt and focused CAPEX.
-
Q3 2024 revenue rose 30% year-over-year to $32.2 million, led by strong Florida growth and improved gross margins. Adjusted EBITDA was $1.3 million, with a $29.5 million cash balance and continued expansion in key markets despite regulatory and market headwinds.
-
Q2 2024 saw revenue rise 36% sequentially to $31.1 million, driven by the VidaCann acquisition and the DAZED! Lounge launch. Gross margin improved to 50.1%, and adjusted EBITDA reached $3.2 million. Management remains cautious on H2 2024 due to consumer demand concerns.